GlassScriptPhysician profile
Brennan Barrett
NPI 1932652104
$3,712.70
in general payments reported to CMS, 2019-2025
36 companies · $628 in 2025
The $628 reported for 2025 was more than what 79% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $510 · 2022: $776 · 2023: $959 · 2024: $840 · 2025: $628.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,365 · Education: $61.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,365.00 |
| Education | $61.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $761.49 | 2021-2025 | Brilinta, Farxiga, Atacand |
| Novartis Pharmaceuticals Corporation | $570.99 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $203.04 | 2021-2025 | Verquvo, Capvaxive |
| Janssen Pharmaceuticals, INC | $183.25 | 2021-2024 | Xarelto |
| Pfizer INC. | $178.28 | 2021-2025 | |
| Alnylam Pharmaceuticals INC. | $162.77 | 2022-2024 | Onpattro |
| Novo Nordisk INC | $152.99 | 2021-2025 | Ozempic |
| Boston Scientific Corporation | $152.05 | 2022-2023 | Watchman Access System |
| Amgen INC. | $144.36 | 2021-2025 | Repatha, Repatha |
| Abbott Laboratories | $129.38 | 2021-2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Scpharmaceuticals INC. | $115.55 | 2023-2025 | |
| Abiomed | $75.46 | 2025 | |
| Amarin Pharma, INC. | $73.01 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $72.36 | 2021-2023 | |
| Kestra Medical Technology Services, INC. | $70.85 | 2024-2025 | Assure Wcd |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brennan Barrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.